抗生素
医学
计算生物学
重症监护医学
生物
药品
药理学
抗感染药
梅德林
抗生素耐药性
作者
Yusuf Emre Özdemir,Serkan Sürme,Meryem Şahin Özdemir,Khalis Mustafayev
标识
DOI:10.1080/17460913.2026.2661277
摘要
. Relevant data on novel antibacterial agents were identified through searches of the Scopus, PubMed, and Web of Science databases, as well as the 2024 WHO report on new and emerging antibiotics, focusing on studies published within the past 5 years. This review summarizes novel antibacterial agents targeting resistant Gram-negative and Gram-positive pathogens, including compounds that are currently under Food and Drug Administration evaluation or recently approved, as well as additional promising candidates under development for the treatment of drug-resistant microorganisms. In addition, a brief overview of the non-traditional agents that have completed the approval process and are now available on the market is also provided.
科研通智能强力驱动
Strongly Powered by AbleSci AI